Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-03-14
1996-10-15
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 8, 514255, 514383, 514396, 514399, 514449, A61K 3141, A61K 31415, A61K 31335
Patent
active
055654789
ABSTRACT:
The present invention provides compositions and methods for the treatment of cancer in a subject wherein compounds of formula I defined herein in combination with paclitaxel or other modified taxane analogs provide enhanced anticancer effects over the effects achieved with the individual compounds.
REFERENCES:
patent: 3717655 (1973-02-01), Godefroi et al.
patent: 4144346 (1979-03-01), Heeres et al.
patent: 4223036 (1980-09-01), Heeres et al.
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4501728 (1985-02-01), Geho et al.
patent: 4837028 (1989-06-01), Allen
Chabner, Cancer Chemotherapy, Lippencott, pp. 1-15 (1990).
DeVita, Cancer, Principles & Practice of Oncology, 3rd ed., Chapter 16, pp. 276-300, Lippencott, (1989).
Felder, et al., J. Pharm. Exp. Therapy., 257:967-971 (1991).
Hupe, et al., J. Biol. Chem., 266:10136-10142 (1991).
Kohn, et al., J. Natl. Cancer Inst., 82:54-60 (1990).
Kohn, et al., Cancer Research, 52:3208-3212 (1992).
Kohn, et al., Cancer Research, 54:935-942 (1994).
Merritt, et al., Biochem. J., 271:515-522 (1990).
Cole, et al., Cancer and Metastasis Reviews, 13:31-44 (1994).
Lin, et al., Cell, 72:269-278 (1993).
Gusovsky, et al., J. Biol. Chem., 268:7768-7772 (1993).
Dinsmore, et al., Cell, 53:769-780 (1988).
Pirollet, et al., Biochemistry, 31:8849-8855 (1992).
Zamansky, et al., J. Investigative Dermatology, 97:985-994 (1991).
Holton, et al., J. Am. Chem. Soc., 116:1597-1601 (1994).
Nicolaou, et al., Nature, 367:630-634 (1994).
Kumar, N., J. Biol. Chem., 256:10435-10441 (1981).
Rowinsky, et al., J. Natl. Cancer Inst., 82:1247-1259 (1990).
Schiff, et al., Nature, 277:665-667 (1979).
McGuire, et al., Ann. Int. Med., 111:273-279 (1989).
Holmes, et al., J. Natl. Cancer Inst., 83:1797-1805 (1991).
Kohn, et al., J. Natl. Cancer Inst., 86:18-24 (1994).
Kohn, et al., American Society for Clinical Oncology, vol. 12, Abstract 814 (1993).
Szoka, et al., Ann. Rev. Biophys. Bioeng., 9:467-508 (1980).
Hope, et al., Chem. Phys. Lip., 40:89-107 (1986).
Holmes, et al., J. Chromatography, 613:317-325 (1993).
Sarosy, et al., J. Clin. Oncol., 10:1165-1170 (1992).
Mason, Am. J. Physiol., 264:C654-C662 (1993).
Kohn Elise C.
Liotta Lance A.
Reed Eddie
Cintins Marianne M.
Spivack Phyllis G.
The United States of America as represented by the Department of
LandOfFree
Combination therapy using signal transduction inhibitors with pa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination therapy using signal transduction inhibitors with pa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy using signal transduction inhibitors with pa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1246488